Tilray | TRLY - Trade Debtors


Tilray reported $109.07M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acasti Pharma USD 20K 0 Sep/2025
Akebia Therapeutics USD 47.03M 19.19M Dec/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
Aurora Cannabis CAD 44.58M 3.68M Mar/2026
Avita Medical AUD 9.11M 2.26M Dec/2025
Canopy Growth CAD 36.29M 104.13M Mar/2026
Cronos Group USD 59.76M 13.41M Jun/2026
Dianthus Therapeutics USD 1.23M 1.18M Mar/2026
Divis Laboratories Ltd INR 29.99B 3.71B Mar/2026
Ionis Pharmaceuticals USD 58.84M 15.16M Jun/2026
IQVIA Holdings USD 3.39B 12M Jun/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
Moderna USD 17M 54M Jun/2026
Organigram Holdings CAD 53.39M 3.45M Mar/2026
Organon & Co USD 1.49B 108M Jun/2026
Revvity USD 709.18M 17.79M Jun/2026
Tectonic Therapeutic USD 0 270K Dec/2023
Tilray USD 109.07M 2M Sep/2025
Viatris USD 3.13B 49.9M Jun/2026
Xeris Pharmaceuticals USD 56.29M 5.24M Mar/2026
Zealand Pharma A/S 259M 81M Mar/2026